PhAST Diagnostics
About:
PhAST Diagnostics develops rapid diagnostic technology to provide actionable information on pathogens.
Website: https://phastdiagnostics.com
Top Investors: Massachusetts Life Sciences Center
Description:
PhAST Diagnostics develops an AI imaging technology for combating antibiotic resistance. Its cloud-based platform provides clinical decision support for doctors, workflow improvement for hospitals, and helps accelerate the drug development process for pharmaceutical companies.
Total Funding Amount:
$15.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2017-01-01
Contact Email:
info(AT)phastdiagnostics.com
Founders:
Kwangmin Son, Roman Stocker
Number of Employees:
11-50
Last Funding Date:
2022-12-14
IPO Status:
Private
© 2024 MyAiNote.com